Vol. 453 No. 5
51 Mr. Bell asked the Minister for Health if his attention has been drawn to development and research in relation to cystic fibrosis and to the fact that there is a breakthrough in relation to a drug which has the potential to assist young people stricken by this illness; if his Department is monitoring those developments; and if he will make a statement on the matter. [9207/95]
Limerick East): I am aware of the considerable research and development work which is being undertaken in the search for new treatments for cystic fibrosis. Much of the research being currently conducted is in the area of biotechnology, including gene therapy and recombinant DNA research.
The breakthrough referred to by the Deputy in respect of a drug which has the potential to assist young people with this illness is assumed to relate to a drug known as dornase alfa, otherwise known as DNase.
The drug is a product of recombinant DNA research and is an enzyme which reduces the viscosity of the mucus, or sputum, present in the airways of those suffering from cystic fibrosis. It is in this manner that essential pulmonary function is improved in these patients.
